· Manaloahealth
Most people don't find out they're at risk for a heart attack until they're having one. That's the uncomfortable truth about cardiovascular disease, still the leading cause of death, and it's exactly why it doesn't have to be that way. The disease builds silently over decades, which means there's a long window where it's invisible on the outside but detectable on the inside. The single most powerful, actionable thing you can do for your longevity is find out where you stand before symptoms ever appear.
The good news is that the tools to do this have gotten dramatically better, and in 2026 the official guidelines caught up. Here are the screening tests worth knowing about, why each one matters, and what to actually ask your doctor for.
Why Early Screening Is the Whole Game
Heart disease isn't an event; it's a process. Plaque accumulates in your arteries gradually, often starting in your 20s and 30s, long before it causes any symptoms. By the time it produces chest pain or a heart attack, the disease is already advanced.
This is why "I feel fine" is not reassurance. The point of screening is to catch the process early, while lifestyle changes and, when appropriate, treatment can still change your entire trajectory. A guiding principle in modern prevention is that lower risk exposure, maintained for longer, produces better outcomes over a lifetime. Time is the most valuable asset you have, and screening is how you put it to work.
The Standard Test Everyone Knows (and Its Limits)
Most adults have had a basic cholesterol panel, which measures total cholesterol, LDL ("bad") cholesterol, HDL ("good") cholesterol, and triglycerides. This is a genuinely useful starting point and everyone should have it. But it has a blind spot: LDL cholesterol measures the amount of cholesterol carried in your LDL particles, not the number of particles. Two people with identical LDL cholesterol can carry very different numbers of artery-damaging particles, and the standard test can't tell them apart. That's where the newer tools come in.
The Tests That Give a Sharper Picture
In March 2026, the American College of Cardiology, the American Heart Association, and nine other medical organizations released a major updated guideline on managing cholesterol and lipids [1]. Several of its recommendations elevated tests that were previously considered optional or specialized. Here's what to know.
1. Apolipoprotein B (ApoB): Counting the Particles
Every artery-clogging lipoprotein particle carries exactly one apoB protein on its surface, so measuring apoB directly counts the number of particles that actually drive artery disease. This makes it a more accurate reflection of cardiovascular risk than standard cholesterol, particularly for people with diabetes, obesity, high triglycerides, or metabolic issues, where the standard LDL number can be misleadingly reassuring [2].
The 2026 guideline recognizes that apoB more accurately reflects risk and can be useful both for refining treatment decisions and for catching risk that LDL alone misses. A practical advantage: apoB is directly measured rather than calculated, and it isn't meaningfully affected by whether you've eaten, so fasting isn't required [2].
2. Lipoprotein(a), or "Lp(a)": The Hidden Genetic Risk
This is the biggest change, and the one most likely to affect you or someone in your family. For the first time in a US guideline, the 2026 recommendations call for measuring Lp(a) at least once in every adult's lifetime [1, 3].
Lp(a) is a cholesterol-carrying particle whose level is set almost entirely by your genes and stays remarkably stable throughout your life. That's what makes it so useful: one test, one time, tells you something important you'd never otherwise know. Elevated Lp(a), defined as 125 nmol/L (about 50 mg/dL) or higher, is associated with roughly a 1.4-fold increased long-term risk of heart attack or stroke, and very high levels carry risk comparable to inherited high-cholesterol conditions [3, 4].
Roughly one in five people has elevated Lp(a) and has no idea, because it's almost never tested. Because it's inherited, a high result should prompt family members to get checked too [4]. Even though targeted treatments are still emerging, knowing you have high Lp(a) is a powerful reason to be aggressive about every other risk factor you can control.
3. Coronary Artery Calcium (CAC) Score: Looking Directly at Your Arteries
If the blood tests estimate risk, the CAC scan comes closer to measuring it directly. It's a quick, noninvasive CT scan (no dye, just a few minutes) that detects and quantifies calcified plaque already present in your heart's arteries. The result is a score in "Agatston units": a score of zero is highly reassuring, while higher scores indicate more plaque and higher risk [5].
The 2026 guideline upgraded CAC scoring to a stronger (Class 1) recommendation for refining risk in people at borderline or intermediate risk, generally men over 40 and women over 45 who are trying to decide whether to start preventive treatment [1, 5]. The power of the CAC scan is that it can reclassify you: an intermediate-risk person with a calcium score of zero has a genuinely low near-term risk, while the same person with a score of 100 or more has risk comparable to a high-risk patient [6]. That clarity can spare you unnecessary medication or, just as importantly, prompt action that prevents a future event.
Don't Forget the Metabolic and Pressure Numbers
Cardiovascular risk doesn't live in your arteries alone. Two other categories of screening are just as actionable.
Blood Sugar and Insulin
Insulin resistance and prediabetes drive an enormous share of age-related disease, and they're often present for years before a diabetes diagnosis. The American Diabetes Association recommends that all adults begin screening for prediabetes and diabetes at age 35, or earlier for those with overweight and additional risk factors, using a simple fasting glucose test or HbA1c, which reflects your average blood sugar over about three months [7, 8]. Anyone already in the prediabetes range (an HbA1c of 5.7 to 6.4 percent) should be retested regularly, because this is precisely the window where lifestyle changes can prevent progression [7]. Catching insulin resistance early is one of the highest-leverage moves in preventive health.
Blood Pressure
High blood pressure is called the "silent killer" for good reason: it usually has no symptoms while it quietly damages your heart, brain, kidneys, and blood vessels. The 2025 AHA/ACC blood pressure guideline reaffirmed a treatment threshold of 130/80 mmHg and emphasized earlier, more attentive control, along with the value of monitoring your pressure at home to catch readings a single office visit might miss [9]. It's one of the cheapest and most consequential numbers you can track.
What to Actually Do With This
You don't need every test tomorrow. But you can bring an informed, specific list to your next appointment. Consider asking your clinician about:
A standard lipid panel, if you haven't had one recently, as your baseline.
A one-time Lp(a) test, since the newest guideline recommends it for every adult and you likely have never had it.
An apoB test, especially if you have diabetes, metabolic issues, or a strong family history, or if your standard numbers look "fine" but you want a clearer read.
A coronary artery calcium scan, if you're at borderline or intermediate risk and trying to decide about preventive treatment.
Fasting glucose or HbA1c, if you're 35 or older or carry metabolic risk factors.
Regular blood pressure checks, ideally including some at home.
Bring your family history with you, since a parent or sibling with early heart disease meaningfully changes your risk picture and what's worth testing.
The Bottom Line
The most important thing to understand about cardiovascular disease is that it gives you a long head start, if you choose to look. The 2026 guidelines made a clear statement: it's never too early to understand your risk, and tools like Lp(a), apoB, and calcium scoring can reveal danger that standard tests miss, often decades before it would otherwise surface. Pair that knowledge with the metabolic and blood pressure basics, and you have a genuinely powerful, actionable blueprint for a longer, healthier life.
Knowing your numbers isn't about anxiety. It's about buying yourself time, and time is exactly what longevity is made of.
Currently treating patients located in:
Colorado, Florida, Hawaii, and Washington!
Click the link to schedule a consultation today!
https://mana-loa.clientsecure.me
-The Mana Loa Health Team
Patient safety is Mana Loa Health's top priority. The information discussed on this blog is not intended to recommend the self management of health problems or wellness. It is not intended to endorse or recommend any particular type of medical treatment or advice. The information provided on this website is for informational purposes and not a substitute for professional medical advice, diagnosis, or treatment. If you have questions or concerns about your health, please talk to your healthcare provider. No information contained on this blog should be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider.
References
2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia. American Heart Association Newsroom, March 2026. https://newsroom.heart.org/news/accaha-issue-updated-guideline-for-managing-lipids-cholesterol
Lower Sooner: How the 2026 Dyslipidemia Guideline Changes Practice. American College of Cardiology, July 2026. https://www.acc.org/Latest-in-Cardiology/Articles/2026/07/01/01/Prioritizing-Health
2026 ACC/AHA/Multisociety Dyslipidemia Guideline Released. National Lipid Association. https://www.lipid.org/nla/2026-accahamultisociety-dyslipidemia-guideline-released
ACC/AHA Issue Updated Guideline for Managing Lipids, Cholesterol. American College of Cardiology, March 2026. https://www.acc.org/about-acc/press-releases/2026/03/13/18/01/accaha-issue-updated-guideline-for-managing-lipids-cholesterol
Key Updates from the 2026 Dyslipidemia Management Guideline. University of Illinois Chicago Drug Information Group, May 2026. https://dig.pharmacy.uic.edu/faqs/2026-2/may-2026-faqs/what-are-key-updates-from-the-2026-acc-aha-aacvpr-abc-acpm-ada-ags-apha-aspc-nla-pcna-guideline-on-dyslipidemia-management/
2026 ACC/AHA Guideline on the Management of Dyslipidemia (full text). Circulation, 2026. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001423
Diagnosis and Classification of Diabetes: Standards of Care in Diabetes 2025. American Diabetes Association, Diabetes Care. https://diabetesjournals.org/care/article/48/Supplement_1/S27/157566/2-Diagnosis-and-Classification-of-Diabetes
Hemoglobin A1C (HbA1c) Test. MedlinePlus, US National Library of Medicine. https://medlineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/
The 2025 AHA/ACC Hypertension Guidelines: Implications for Cardiovascular and Renal Risk. PMC (open access), 2025. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12379440/